Biocon receives EU approval for Biosimilar facility
July 05, 2018 | Thursday | News
The Sterile Drug Product manufacturing facility in Bengaluru was inspected by the European agencies in March 2018.
Biocon Ltd, Asia’s premier biopharmaceutical company, has announced that it has received the EU GMP certification for its Sterile Drug Product manufacturing facility in Bengaluru, which was inspected by the European agencies in March 2018.
This facility is used for the manufacturing of Biocon’s portfolio of biosimilars. Biocon remains committed to global standards of quality and compliance.
